The John B. Amos Cancer Center has plans to acquire new radiation therapy technology, officials said Tuesday.
The $10.5 million project will upgrade and add several pieces of state-of-the-art equipment to the local center. The new equipment will help the local center perform three things:
• Image guided radiation therapy
Never miss a local story.
• Rapid Arc radiation therapy
• Enhanced stereotactic radiosurgery
IGRT will help pinpoint tumor sites and make sure the tumor is in the same position each treatment session. Rapid Arc will deliver treatments two to eight times faster than conventional therapy — which should allow for more precision since there will be less chance for a patient or tumor to move during treatment. And stereotactic radiosurgery will allow patients to receive non-invasive treatments that don’t harm healthy tissue or involve traditional surgery.
The John B. Amos Cancer Center will partner with Varian Medical Systems, a Palo Alto, Calif.-based manufacturer of medical technology for treating cancer and other conditions, to offer these advanced services.
“We are very excited about this new partnership with Varian and the advances in technology and benefit it will bring to our patients,” Doug Ciuba, the local center’s medical director of radiation oncology, said in a statement. “No other cancer treatment center in our region can deliver this level of care for those patients needing radiation oncology services.”
The cancer center will acquire equipment such as:
• Three linear accelerators
• GE 16-slice computerized tomography simulator
• High Dose Rate Brachytherapy equipment
• Oncology electronic medical record system
Old equipment will be replaced in phases from November 2009 to September 2010 to make sure ongoing patient treatment isn’t disrupted.
The John B. Amos Cancer Center offers an outpatient medical and radiation oncology, infusion therapy, oncology pharmacy and support services for patients and families. From July 2008 to June 2009, there were more than 161,000 patient visits to the center.